CING

Cingulate Inc

4.63

-0.45-8.86%

After Hours: 4.629 -0.00 -0.03%19:52 01/09 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE5.01/5.08

TODAY RANGE4.600-5.13

VOL438.35K

MARKET CAP33.26M

52 WEEK RANGE3.200-6.01

AVG VOL (3M)188.83K

% TURNOVER6.10%

TURNOVER--

P/E (TTM)-0.8656

% RANGE10.43%

EPS(TTM)-5.3487

P/E(FORWARD)-1.1184

P/B7.97

BVPS0.5811

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP30.81M

SHARES OUTSTANDING7.18M

NEXT EARNINGS--

FREE FLOAT6.66M

LOT SIZE1

EX-DATE08/09/2024

News

Press Releases

Financial Reports

Profile

TipRanks·01/02 22:03
Cingulate continues stock-for-debt exchanges to reduce liabilities
Reuters·01/02 21:31
Cingulate Inc. Issues Unregistered Shares to Lenders in Debt Exchange
TipRanks·12/16/2025 11:55
Roth MKM Reaffirms Their Buy Rating on Cingulate Inc (CING)
TipRanks·12/15/2025 14:28
Cingulate Inc Reinstates Shane Schaffer as CEO
Reuters·12/15/2025 14:16
CINGULATE INC: JOHN ROBERTS WILL NO LONGER SERVE AS EXEC CHAIRMAN BUT WILL CONTINUE TO SERVE AS CHAIRMAN OF BOARD
Reuters·12/15/2025 14:15
Cingulate Inc. Revises CEO Compensation Terms Following Administrative Leave
Dow Jones·12/08/2025 10:29
Cingulate Is Maintained at Buy by Ascendiant Capital
Dow Jones·12/08/2025 10:29
Cingulate Price Target Cut to $58.00/Share From $62.00 by Ascendiant Capital
Dow Jones·11/19/2025 18:10
Cingulate Price Target Cut to $16.00/Share From $17.00 by Roth Capital
Dow Jones·11/19/2025 18:10
Cingulate Is Maintained at Buy by Roth Capital
TipRanks·11/19/2025 00:55
Cingulate price target lowered to $16 from $17 at Roth Capital
Reuters·11/18/2025 21:28
Cingulate Inc. Signs Exclusive Commercial Supply Agreement with Bend Bio Sciences
TipRanks·11/15/2025 16:25
Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment
Seeking Alpha·11/13/2025 18:04
Cingulate reports Q3 results
TipRanks·11/13/2025 13:16
Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year

Same Industry

Name/Symbol

Change%

Price

Cingulate Inc

CING

-8.86%

4.63

Regeneron Pharmaceuticals

REGN

-0.56%

796.55

GridAI Tech

GRDX

+3.32%

4.67

BIONTECH

BNTX

+1.01%

99.85

United Therapeutics Corp.

UTHR

-1.55%

483.23

Vertex Pharmaceuticals Inc

VRTX

-1.24%

463.86

Siga Technologie

SIGA

-2.36%

6.61

Moderna

MRNA

+1.30%

34.30

Charles Riv Labs Intl Inc

CRL

+2.51%

220.91

Medpace Holdings

MEDP

-0.84%

595.00

Talphera Inc

TLPH

-2.75%

1.06

ICON PLC

ICLR

-3.63%

181.38

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

-0.32%

242.41

MOLECULAR PARTNERS AG

MOLN

-3.53%

4.10

Arcturus Therape

ARCT

+0.15%

6.78

Gilead Sciences Inc

GILD

+0.36%

121.10

PRA Health

PRAH

165.21

Incyte Corp

INCY

+0.90%

106.87

Aptevo Therapeutics Inc

APVO

+5.00%

9.66

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.